Public Education & Campaign Groups

Founded in 2020, the Autistic Psychedelic Community (APC) is a Los Angeles-based peer support and co-learning network focused on the intersection of psychedelics and neurodivergent conditions including autism and ADHD, offering psychedelic integration support, panel discussions with researchers, and academic partnerships. Cited in peer-reviewed research, the APC promotes neurodiversity-affirming approaches to psychedelic practice and safe access.

Policy-focused organization producing legislative analysis and implementation guidance on affordable, state-regulated psychedelic care pathways.

US-based nonprofit institute founded by Brazilian anthropologist Dr. Bia Labate that bridges psychedelic plant medicine traditions and emerging clinical science, producing research and accessible cultural commentary on ayahuasca, psilocybin, and other plant medicines while centering Indigenous reciprocity, racial equity, and social justice. Chacruna hosts annual interdisciplinary conferences since 2018, operates a Racial Equity and Access Committee, and amplifies voices of Indigenous peoples, women, queer communities, and the Global South in psychedelic science and policy.

Grassroots campaign network focused on decriminalizing entheogenic plants and fungi through local policy campaigns, public education, and community organizing.

The European Federation of Neurological Associations (EFNA) is a Brussels-based umbrella organization representing 21 pan-European neurology patient groups, advocating for improved access and resources for people with neurological disorders. EFNA participates as a patient advocacy partner in the PsyPal consortium, the first EU-funded multi-site psilocybin clinical trial (€6.5M) studying psilocybin for psychological distress in palliative care neurological patients.

Nonprofit campaign and implementation-support organization focused on expanding and protecting safe, affordable, state-regulated psychedelic therapy access, including Oregon and Colorado programs.

Veteran-serving nonprofit supporting access to psychedelic programs and advocating policy pathways that expand safe treatment options for veterans and their families.

Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit founded by the late Dr. Parth Gandhi to advance psychedelic-assisted therapy through education, research, and advocacy in the Intermountain West. SCPTR organizes the annual Intermountain Psychedelic Symposium and supports practitioners, researchers, and policy reform in the region.

Global youth-led network advocating evidence-based drug policy reform through campus organizing, policy campaigns, and public education that include psychedelic reform issues.

Veteran-focused nonprofit advocating expanded access to psychedelic-assisted therapies, especially for PTSD and related conditions, through policy engagement and public education.